...
首页> 外文期刊>Journal of biomedical materials research, Part A >Study on the Drug Release Property of Cholesteryl End-Functionalized Poly(epsilon-caprolactone)Microspheres
【24h】

Study on the Drug Release Property of Cholesteryl End-Functionalized Poly(epsilon-caprolactone)Microspheres

机译:胆固醇末端官能化聚ε-己内酯微球的释药性能研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

End-functionalized poly/oligo(e-caprolactone)s were synthesized through the ring-opening polymerization of e-caprolactone initiated by cholesterol with a hydroxyl group. Using the end-functionalized poly/oligo(e-caprolactone)s with different molecular weights, the microsphere drug delivery systems were fabricated using a convenient melting-emulsion method. The drug release properties of microspheres were investigated with the presence of an enzyme, Pseudomonas cepacia lipase, as well as in the absence of the enzyme. The release profiles can be fitted nicely by the classical empirical exponential expression. Under the hydrolytic condition, the drug release is mainly controlled by Fickian diffusion, and the high molecular weight of the matrix results in a slower drug release rate. Under the enzymatic condition, the drug release is dominated by combined degradation and diffusion mechanism, and the high molecular weight sample exhibits a faster release rate that is mainly caused by the higher degradation rate of the sample with lower cholesteryl moiety content.
机译:通过由具有羟基的胆固醇引发的ε-己内酯的开环聚合来合成末端官能化的聚/寡(ε-己内酯)。使用具有不同分子量的末端官能化的聚/低聚(ε-己内酯),使用便利的熔融乳液法制备了微球药物递送系统。在存在酶,假单胞菌脂肪酶和不存在酶的情况下,研究了微球的药物释放特性。释放曲线可以通过经典的经验指数表达式很好地拟合。在水解条件下,药物释放主要受菲克扩散控制,基质的高分子量导致药物释放速率降低。在酶促条件下,药物的释放主要受降解和扩散机制的共同作用,高分子量样品的释放速率较快,这主要是由于胆固醇含量较低的样品降解率较高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号